Description
| SKU: | RPCB2608 |
| Size: | 100 μg |
| Tag: | N-His |
| Reactivity: | SARS-CoV-2 |
| Protein Description: | Recombinant SARS-CoV-2(2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1- Ala419) of SARS-COV-2(2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus. |
| Endotoxin: | < 1 EU/μg of the protein by LAL method. |
| Purity: | ≥ 95 % as determined by SDS-PAGE;≥ 95 % as determined by HPLC. |
| Formulation: | Supplied as a 0.22 μm filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% glycerol, pH8.0.Contact us for customized product form or formulation. |
| Gene ID: | 43740575 |
| Storage: | Store at -70℃. This product is stable at ≤ -70℃ for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze-thaw cycles. |
| Swiss-Prot: | QHD43423.2 |
 | Recombinant SARS-CoV-2 Nucleocapsid Protein was determined by SDS-PAGE under reducing conditions with Coomassie Blue. |
 | The purity of SARS-COV-2 Nucleocapsid Protein with His tag (Cat.RP01264) was greater than 95% as determined by SEC-HPLC. |
 | Immobilized Recombinant SARS- COV-2 Nucleocapsid at 2μg/mL (100 μL/well) can bind Anti-Nucleocapsid antibody with a linear range of 0. 12-1. 64 ng/mL. |
 | Immobilized Recombinant SARS- CoV-2 envelope Protein at 2μg/mL (100 μL/well) can bind Recombinant SARS-CoV-2 Nucleocapsid protein, the EC50 of Recombinant SARS-CoV-2 Nucleocapsid protein is 41. 10 ng/mL. |
